Health News
Javelin Pharmaceuticals, Inc. (NYSE – Amex: JAV) recently reported its audited financial results for the full year and quarter ending December 31, 2009.
Corporate Highlights:
– On January 15, 2009 Javelin entered into an exclusive European marketing partnership for Dyloject with Therabel N.V., worth up to $71.0 million, including $7 million upfront, future milestone payments and royalties on sales.
…..Click here to read more
Intuitive Surgical, Inc. (NASDAQ: ISRG), the leader in operative surgical robotics, will hold its quarterly conference call to discuss first quarter, 2010 results, Thursday, April 15, at 4:30 p.m. Eastern Time.
ExonHit Therapeutics (Paris:ALEHT) announced its consolidated financial results for the year ending December 31, 2009.
In Therapeutics:
* For its internal programs, the strategy of the Company is to bring drug candidates through proof-of-concept studies, and then partner the programs to accelerate product development. The milestone payments received will allow ExonHit to finance the development of other drug candidates and advance its diagnostics programs. …..Click here to read more
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) reported financial results for the fourth quarter and full year ended December 31, 2009.
Financial Results
As of December 31, 2009, cash, cash equivalents and investments totaled $40.2 million compared to $55.6 million at December 31, 2008. Additionally, in December 2009 the Company earned a milestone payment of €3.0 million from Merck KGaA and recognized this milestone payment as revenue in 2009. The Company received $4.1 million in payment of this milestone in the first quarter of 2010 which is not included in December 31, 2009 cash. …..Click here to read more
BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) announced that the Company plans to release its financial results for the three and twelve months ended December 31, 2009, on Thursday, March 11, 2010 after the close of market. The Company will host a conference call and audio webcast to discuss its fourth quarter and year-end financial results, product development programs and business activities at 8:30 a.m. EST Friday, March, 12, 2010.
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its third quarter of Fiscal Year 2010 ended January 31, 2010, prior to the market opening on Thursday, March 11, 2010 and will hold a conference call to discuss its financial results at 10 a.m. Eastern Time.
GTC Biotherapeutics, Inc. (Nasdaq: GTCB) (“GTC”) announced that its financial results for the fourth quarter and year end 2009 will be released on Friday, March 12, 2010 followed by a webcast conference call starting at 10:00 a.m. Eastern Time.
* 2009 record revenues of $234.8 million
* 2009 net income of $31.1 million, or $1.02 per share, representing eighth consecutive year of profitability
* 2009 cash and accounts receivable balance of $157.8 million, including $102.9 million of cash and $54.9 million of accounts receivable
* 2010 forecast anticipates total revenues of $235 to $255 million and net income of $20 to $30 million
Emergent BioSolutions Inc. (NYSE: EBS) announced its financial results for the full year ended December 31, 2009.
…..Click here to read more
Natus Medical Incorporated (Nasdaq:BABY) announced financial results for the fourth quarter and full year ended December 31, 2009.
For the fourth quarter ended December 31, 2009, Natus reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008. …..Click here to read more
BioReference Laboratories, Inc. (NASDAQ: BRLI) (Numbers in Thousands Except Per Share Data or where otherwise noted) released its first quarter, fiscal year 2010 earnings for the three months ending January 31. The Company had net revenues for the quarter of $99,261, an increase of 31% over the $75,735 of net revenues recorded in the first quarter …..Click here to read more
Financial News Diamonds
